In this systematic review and meta-analysis, study authors aimed to evaluate the health-related quality of life of men with osteoporosis or osteoporotic fractures.
Osteoporosis and low bone density contribute to age-related hearing loss.
With the rate of a second fracture in high-risk patients still unknown, researchers evaluated the recurrence of fx in certain vulnerable subgroups.
Using the 2005 to 2010 NHANES, the researchers examined the association between osteoporosis risk and the effect of sleep quality and duration in adults.
Using the FOS, the FOS Offspring, and CHAMP studies, researchers studied the relationship between dietary fiber and risk for hip fracture in older men.
A post hoc analysis of the phase 3 ACTIVE trial of abaloparatide for fracture prevention in postmenopausal women was presented at ENVISION, the 2021 AACE Annual Meeting.
The age-adjusted prevalence of osteoporosis at either the femur neck or lumbar spine or both was 12.6% among adults aged 50 years and older in 2017 to 2018.
Authors of the review discuss primary considerations and areas for future research regarding bisphosphonate drug holiday duration in patients with osteoporosis.
In new joint guidelines issued by bone health experts, recommendations are presented for managing osteoporosis therapy in the context of COVID-19 vaccination.
ASBMR, AACE, Endocrine Society, ECTS, IOF, and NOF developed guidance on COVID-19 vaccination and osteoporosis management.
Study authors utilized electronic questionnaires to assess the impact the COVID-19 pandemic has had on osteoporosis management.